Literature DB >> 8425454

Hypercholesterolemia in primary biliary cirrhosis is no risk factor for atherosclerosis.

A Propst, T Propst, M Lechleitner, F Hoppichler, H Kathrein, W Vogel, G Judmaier, E Knapp, H Braunsteiner.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8425454     DOI: 10.1007/bf01307562

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  4 in total

1.  Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis.

Authors:  K Desai; P Mistry; C Bagget; A K Burroughs; M F Bellamy; J S Owen
Journal:  Lancet       Date:  1989-04-01       Impact factor: 79.321

2.  Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia.

Authors:  J R Patsch; J B Karlin; L W Scott; L C Smith; A M Gotto
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

3.  Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia.

Authors:  M Seed; F Hoppichler; D Reaveley; S McCarthy; G R Thompson; E Boerwinkle; G Utermann
Journal:  N Engl J Med       Date:  1990-05-24       Impact factor: 91.245

4.  Lipoprotein abnormalities in patients with early primary biliary cirrhosis.

Authors:  A Aly; K Carlson; C Johansson; P Kirstein; S Rössner; L Wallentin
Journal:  Eur J Clin Invest       Date:  1984-04       Impact factor: 4.686

  4 in total
  2 in total

1.  Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis.

Authors:  M Longo; A Crosignani; P M Battezzati; C Squarcia Giussani; P Invernizzi; M Zuin; M Podda
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

2.  Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis.

Authors:  Carmen M Stanca; Nancy Bach; Jorge Allina; Carol Bodian; Henry Bodenheimer; Joseph A Odin
Journal:  Dig Dis Sci       Date:  2008-04-05       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.